Clinical Trial Update: Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on using Fludeoxyglucose F18 PET imaging to assess patients with locally advanced non-small cell lung cancer before and after trea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Fludeoxyglucose F18 (Fludeoxyglucose F18)

Snippet

Sponsor: American College of Radiology Imaging Network | Conditions: Lung Cancer | Phase 2 | Status: UNKNOWN